6.91
price up icon5.66%   +0.37
after-market  Dopo l'orario di chiusura:  6.82  -0.09   -1.30%
loading

NeuroPace Inc Borsa (NPCE) Ultime notizie

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

pulisher
Investing.com

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference - The Globe and Mail

pulisher
The Globe and Mail

Market Watch Highlights: NeuroPace Inc (NPCE) Ends on an Downturn Note at 7.53 – DWinneX - The Dwinnex

pulisher
The Dwinnex

NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions - Yahoo Finance

pulisher
Yahoo Finance

Trend Tracker for (NPCE) - Stock Traders Daily

pulisher
Stock Traders Daily

Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Contrasting Tactile Systems Technology (NASDAQ:TCMD) and NeuroPace (NASDAQ:NPCE) - Defense World

pulisher
Defense World

NeuroPace (NPCE) Price Target Increased by 17.52% to 9.35 - MSN

pulisher
MSN

NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still ... - Yahoo Movies UK

pulisher
Yahoo Movies UK

NeuroPace to Participate in Two Healthcare Conferences in May - Investing.com India

pulisher
Investing.com India

Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat

pulisher
MarketBeat

Brain Computer Interface Technology Market 2024 Trends with Analysis on Key Players NeuroPace Inc, Emotiv Inc ... - Amoré

pulisher
Amoré

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

pulisher
Insider Monkey

NeuroPace's (NPCE) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World

pulisher
Defense World

Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat

pulisher
MarketBeat

Q2 2024 EPS Estimates for NeuroPace, Inc. Decreased by Analyst (NASDAQ:NPCE) - Defense World

pulisher
Defense World

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion - Investing.com India

pulisher
Investing.com India

FY2028 Earnings Estimate for NeuroPace, Inc. Issued By Leerink Partnrs (NASDAQ:NPCE) - Defense World

pulisher
Defense World

NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript - Seeking Alpha

pulisher
Seeking Alpha

Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares? - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

NeuroPace, Inc. to Post FY2028 Earnings of $0.27 Per Share, Leerink Partnrs Forecasts (NASDAQ:NPCE) - MarketBeat

pulisher
MarketBeat

NeuroPace First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

pulisher
Simply Wall St

Brain Computer Interfaces in Medicine Market 2031 Key Insights and Leading Players NeuroPace, Inc, Mindmaze - Motions Online

pulisher
Motions Online

NeuroPace, Inc. to Post FY2028 Earnings of $0.27 Per Share, Leerink Partnrs Forecasts (NASDAQ:NPCE) - MarketBeat

pulisher
MarketBeat

Neuropace's Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies ... - TipRanks

pulisher
TipRanks

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

pulisher
MarketBeat

NeuroPace (NASDAQ:NPCE) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

pulisher
MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

pulisher
Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

pulisher
MarketBeat

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update - 08.05.2024 - wallstreet:online

pulisher
wallstreet:online

Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates

pulisher
Zacks Investment Research

Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

NeuroPace (NPCE) Set to Announce Quarterly Earnings on Wednesday - Defense World

pulisher
Defense World

Orbimed Advisors Llc Sells 4,674 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat

pulisher
MarketBeat

Brain Computer Interfaces in Medicine Market 2024 [Key Trends] | NeuroPace Inc, Mindmaze SA, G.TEC - Motions Online

pulisher
Motions Online

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

pulisher
GlobeNewswire Inc.

OrbiMed Advisors sells over $7 million in NeuroPace stock - Investing.com South Africa

pulisher
Investing.com South Africa

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

pulisher
GlobeNewswire Inc.

The Latest Analyst Ratings For NeuroPace

pulisher
Benzinga

NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Call Transcript - Yahoo Finance

pulisher
Yahoo Finance

Neuropace, Inc.'s New Economy & Political Environment Risk – A Cause for Worry? - TipRanks.com - TipRanks

pulisher
TipRanks

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

pulisher
GlobeNewswire Inc.

Neuropace earnings beat by $0.09, revenue topped estimates - Investing.com ZA - Investing.com South Africa

pulisher
Investing.com South Africa

A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts

pulisher
Benzinga

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

pulisher
GlobeNewswire Inc.

NeuroPace Announces Chief Legal Officer Irina Ridley's Departure - TipRanks.com - TipRanks

pulisher
TipRanks

CLO Of Epilepsy Treatment Biz NeuroPace To Depart - Law360

pulisher
Law360

NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

pulisher
Benzinga
$257.21
price up icon 0.28%
medical_devices STE
$222.88
price down icon 0.15%
medical_devices ZBH
$115.15
price up icon 0.62%
medical_devices PHG
$27.14
price down icon 0.80%
$118.77
price up icon 0.31%
medical_devices EW
$86.89
price down icon 1.14%
Capitalizzazione:     |  Volume (24 ore):